Showing results (31-40 of 862) with videos related to
Sort By:
Pageof 87
Clinical and Experimental Pharmacology & Physiology|March 7, 2017
INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cellsHaiwen Chen, Hongliang Li, Qi ChenMolecular and Clinical Oncology|April 14, 2016
Hydronephrosis associated with ureteral metastasis of prostate cancer: A rare case reportDong Zhang, Hongliang Li, Weimin GanCurrent Drug Targets|August 5, 2015
Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and ChallengesYaxing Zhang, Xiao-Jing Zhang, Hongliang LiClinical Science (London, England : 1979)|April 8, 2020
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19Rhian M Touyz, Hongliang Li, Christian DellesChemistry & Biodiversity|March 14, 2023
Germacrane-Type Sesquiterpene Lactones from Achillea millefolium L. and Their Anti-Inflammatory ActivityHongliang Li, Haji Akber Aisa, Jun LiIEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|April 20, 2016
Low-Delay Rate Control for Consistent Quality Using Distortion-Based Lagrange MultiplierMiaohui Wang, King Ngi Ngan, Hongliang LiTrends in Molecular Medicine|November 30, 2021
Targeting ACC for NASH resolutionXiao-Jing Zhang, Jingjing Cai, Hongliang LiTrends in Endocrinology and Metabolism: TEM|August 23, 2018
Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver DiseaseJingjing Cai, Xiao-Jing Zhang, Hongliang LiPhysiological Reviews|December 20, 2018
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular DiseasesMeng Xu, Peter P Liu, Hongliang LiMedicinal Research Reviews|May 31, 2018
Progress and challenges in the prevention and control of nonalcoholic fatty liver diseaseJingjing Cai, Xiao-Jing Zhang, Hongliang LiPageof 87